Edition:
India

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

9.50USD
17 Nov 2017
Change (% chg)

$0.15 (+1.60%)
Prev Close
$9.35
Open
$9.40
Day's High
$9.50
Day's Low
$9.27
Volume
7,033
Avg. Vol
32,761
52-wk High
$21.59
52-wk Low
$7.22

Select another date:

Mon, Nov 13 2017

BRIEF-Gemphire Therapeutics reports qtrly loss of $0.82‍​/shr

* Gemphire Therapeutics Inc qtrly loss per share $0.82‍​ Source: (http://bit.ly/2iaJuNF) Further company coverage:

BRIEF-Gemphire announces plans to advance gemcabene into phase 3 clinical development

* Gemphire announces plans to advance gemcabene into phase 3 clinical development

BRIEF-Gemphire Therapeutics Inc files mixed shelf of up to $175 million - SEC filing ‍​

* Gemphire therapeutics inc files mixed shelf of up to $175 million - SEC filing ‍​ Source text: (http://bit.ly/2vRDX2x) Further company coverage:

BRIEF-Gemphire Therapeutics Inc posts Q2 net loss $0.99/shr

* Gemphire announces second quarter 2017 financial results and provides corporate update

BRIEF-Gemphire announces top-line data from royal-1 phase 2b clinical trial in hypercholesterolemic patients

* Gemphire announces top-line data from royal-1 phase 2b clinical trial in hypercholesterolemic patients

BRIEF-Gemphire enters into $15 mln term loan agreement with Silicon Valley Bank

* Gemphire enters into $15 million term loan agreement with silicon valley bank

BRIEF-Gemphire Therapeutics reports departure of CEO

* Gemphire Therapeutics announces departure of its chief executive officer Mina Sooch

Select another date: